Guangxi Wuzhou Zhongheng Group Co Ltd Net Assets

Latest as of March 2026: CN¥6.63 Billion CNY ≈ $970.69 Million USD

Guangxi Wuzhou Zhongheng Group Co Ltd net assets. Based on the latest financial reports, Guangxi Wuzhou Zhongheng Group Co Ltd (600252) has net assets worth CN¥6.63 Billion CNY (≈ $970.69 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥10.29 Billion ≈ $1.51 Billion USD) and total liabilities (CN¥3.65 Billion ≈ $534.68 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore 600252 shareholders equity momentum to track the company's year-over-year net asset growth rate.

Key Net Assets Metrics

Metric Value
Current Net Assets CN¥6.63 Billion
% of Total Assets 64.48%
Annual Growth Rate 15.06%
5-Year Change -22.39%
10-Year Change 26.64%
Growth Volatility 39.11

Net Assets of Guangxi Wuzhou Zhongheng Group Co Ltd (1997–2025)

Net assets of Guangxi Wuzhou Zhongheng Group Co Ltd from 1997 to 2025. This chart illustrates how Guangxi Wuzhou Zhongheng Group Co Ltd's net assets have evolved over time, based on quarterly financial data. See Guangxi Wuzhou Zhongheng Group Co Ltd (600252) balance sheet quality index to measure how much of total assets are equity-financed.

Annual Net Assets for Guangxi Wuzhou Zhongheng Group Co Ltd (1997–2025)

The table below shows the annual net assets of Guangxi Wuzhou Zhongheng Group Co Ltd from 1997 to 2025. For live market cap and overall valuation, see 600252 market cap.

Year Net Assets Change
2025-12-31 CN¥6.74 Billion
≈ $986.86 Million
-10.26%
2024-12-31 CN¥7.51 Billion
≈ $1.10 Billion
-9.21%
2023-12-31 CN¥8.28 Billion
≈ $1.21 Billion
-0.15%
2022-12-31 CN¥8.29 Billion
≈ $1.21 Billion
-4.61%
2021-12-31 CN¥8.69 Billion
≈ $1.27 Billion
+5.62%
2020-12-31 CN¥8.23 Billion
≈ $1.20 Billion
+28.61%
2019-12-31 CN¥6.40 Billion
≈ $936.15 Million
+7.88%
2018-12-31 CN¥5.93 Billion
≈ $867.77 Million
+5.96%
2017-12-31 CN¥5.60 Billion
≈ $818.98 Million
+5.09%
2016-12-31 CN¥5.33 Billion
≈ $779.28 Million
+7.48%
2015-12-31 CN¥4.95 Billion
≈ $725.03 Million
-16.27%
2014-12-31 CN¥5.92 Billion
≈ $865.96 Million
+60.41%
2013-12-31 CN¥3.69 Billion
≈ $539.83 Million
+18.80%
2012-12-31 CN¥3.11 Billion
≈ $454.39 Million
+55.23%
2011-12-31 CN¥2.00 Billion
≈ $292.73 Million
+49.67%
2010-12-31 CN¥1.34 Billion
≈ $195.58 Million
+131.67%
2009-12-31 CN¥576.93 Million
≈ $84.42 Million
+27.65%
2008-12-31 CN¥451.95 Million
≈ $66.13 Million
+8.96%
2007-12-31 CN¥414.81 Million
≈ $60.70 Million
+16.21%
2006-12-31 CN¥356.94 Million
≈ $52.23 Million
-7.31%
2005-12-31 CN¥385.08 Million
≈ $56.35 Million
-19.15%
2004-12-31 CN¥476.29 Million
≈ $69.70 Million
+8.52%
2003-12-31 CN¥438.88 Million
≈ $64.22 Million
+2.47%
2002-12-31 CN¥428.29 Million
≈ $62.67 Million
+7.26%
2001-12-31 CN¥399.28 Million
≈ $58.43 Million
+6.32%
2000-12-31 CN¥375.55 Million
≈ $54.95 Million
+152.44%
1999-12-31 CN¥148.77 Million
≈ $21.77 Million
-6.31%
1998-12-31 CN¥158.79 Million
≈ $23.24 Million
+19.50%
1997-12-31 CN¥132.88 Million
≈ $19.44 Million
--

Equity Component Analysis

This analysis shows how different components contribute to Guangxi Wuzhou Zhongheng Group Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 4919.0% over the analyzed period, indicating profitable operations and earnings retention.

Guangxi Wuzhou Zhongheng Group Co Ltd Net Assets Breakdown (December 2025)

Guangxi Wuzhou Zhongheng Group Co Ltd net assets breakdown by equity component as of December 2025.

Component Amount Percentage
Retained Earnings CN¥1.56 Billion 29.12%
Other Components CN¥3.81 Billion 70.88%
Total Equity CN¥5.37 Billion 100.00%

Guangxi Wuzhou Zhongheng Group Co Ltd Competitors by Market Cap

The table below lists competitors of Guangxi Wuzhou Zhongheng Group Co Ltd ranked by their market capitalization.

Company Market Cap
ZHEJIANG ASIA-PACIFIC MECHANICAL & ELECTRONIC CO LTD
SHE:002284
$1.02 Billion
Beijing Jingyuntong Technology Co Ltd
SHG:601908
$1.02 Billion
Suzhou Recodeal Interconnect System Co Ltd
SHG:688800
$1.02 Billion
Edan Instruments Inc
SHE:300206
$1.02 Billion
Ningbo Cixing
SHE:300307
$1.02 Billion
BIRLASOFT LIMITED
NSE:BSOFT
$1.02 Billion
Central Plains Environment Protection Co Ltd
SHE:000544
$1.02 Billion
Suzhou Medsys Tech Co Ltd
SHG:603990
$1.02 Billion

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Guangxi Wuzhou Zhongheng Group Co Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from 6,022,749,391 to 5,369,181,534, a change of -653,567,857 (-10.9%).
  • Net loss of 357,088,534 reduced equity.
  • Dividend payments of 55,286,944 reduced retained earnings.
  • Other comprehensive income decreased equity by 859,078,610.
  • Other factors increased equity by 617,886,230.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income CN¥-357.09 Million -6.65%
Dividends Paid CN¥55.29 Million -1.03%
Other Comprehensive Income CN¥-859.08 Million -16.0%
Other Changes CN¥617.89 Million +11.51%
Total Change CN¥- -10.85%

Book Value vs Market Value Analysis

This analysis compares Guangxi Wuzhou Zhongheng Group Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 1.30x
  • The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
  • The price-to-book ratio has decreased from 27.45x to 1.30x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
1997-12-31 CN¥0.08 CN¥2.19 x
1998-12-31 CN¥0.10 CN¥2.19 x
1999-12-31 CN¥0.09 CN¥2.19 x
2000-12-31 CN¥0.23 CN¥2.19 x
2001-12-31 CN¥0.25 CN¥2.19 x
2002-12-31 CN¥0.26 CN¥2.19 x
2003-12-31 CN¥0.28 CN¥2.19 x
2004-12-31 CN¥0.28 CN¥2.19 x
2005-12-31 CN¥0.21 CN¥2.19 x
2006-12-31 CN¥0.23 CN¥2.19 x
2007-12-31 CN¥0.26 CN¥2.19 x
2008-12-31 CN¥0.34 CN¥2.19 x
2009-12-31 CN¥0.18 CN¥2.19 x
2010-12-31 CN¥0.44 CN¥2.19 x
2011-12-31 CN¥0.61 CN¥2.19 x
2012-12-31 CN¥0.95 CN¥2.19 x
2013-12-31 CN¥1.12 CN¥2.19 x
2014-12-31 CN¥1.71 CN¥2.19 x
2015-12-31 CN¥1.43 CN¥2.19 x
2016-12-31 CN¥1.52 CN¥2.19 x
2017-12-31 CN¥1.57 CN¥2.19 x
2018-12-31 CN¥1.74 CN¥2.19 x
2019-12-31 CN¥1.87 CN¥2.19 x
2020-12-31 CN¥2.00 CN¥2.19 x
2021-12-31 CN¥1.93 CN¥2.19 x
2022-12-31 CN¥1.90 CN¥2.19 x
2023-12-31 CN¥1.92 CN¥2.19 x
2024-12-31 CN¥1.79 CN¥2.19 x
2025-12-31 CN¥1.69 CN¥2.19 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Guangxi Wuzhou Zhongheng Group Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): -6.65%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -20.42%
  • • Asset Turnover: 0.17x
  • • Equity Multiplier: 1.87x
  • Recent ROE (-6.65%) is below the historical average (9.51%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
1997 17.74% 16.66% 0.42x 2.56x CN¥9.70 Million
1998 16.81% 18.44% 0.39x 2.33x CN¥10.26 Million
1999 21.93% 22.42% 0.42x 2.33x CN¥16.87 Million
2000 7.12% 17.01% 0.26x 1.59x CN¥-10.61 Million
2001 7.44% 15.31% 0.28x 1.76x CN¥-10.00 Million
2002 6.61% 9.54% 0.36x 1.91x CN¥-13.92 Million
2003 6.11% 7.89% 0.31x 2.50x CN¥-17.03 Million
2004 0.48% 0.44% 0.27x 4.07x CN¥-41.52 Million
2005 -28.71% -29.62% 0.20x 4.82x CN¥-129.41 Million
2006 5.86% 6.37% 0.31x 3.00x CN¥-14.63 Million
2007 8.94% 12.80% 0.25x 2.77x CN¥-4.35 Million
2008 10.56% 7.48% 0.60x 2.35x CN¥2.48 Million
2009 22.14% 17.65% 0.47x 2.65x CN¥68.94 Million
2010 29.91% 28.52% 0.47x 2.23x CN¥265.32 Million
2011 18.77% 32.59% 0.30x 1.95x CN¥175.21 Million
2012 22.08% 35.15% 0.42x 1.50x CN¥374.11 Million
2013 20.15% 18.58% 0.66x 1.64x CN¥374.01 Million
2014 26.96% 49.61% 0.40x 1.36x CN¥1.00 Billion
2015 10.51% 38.73% 0.22x 1.24x CN¥25.07 Million
2016 9.20% 29.30% 0.26x 1.22x CN¥-42.81 Million
2017 10.82% 29.54% 0.30x 1.23x CN¥45.62 Million
2018 10.35% 18.59% 0.46x 1.22x CN¥20.72 Million
2019 11.65% 19.53% 0.49x 1.23x CN¥105.60 Million
2020 8.22% 15.31% 0.31x 1.75x CN¥-122.13 Million
2021 4.63% 9.71% 0.27x 1.80x CN¥-355.41 Million
2022 1.21% 2.91% 0.23x 1.80x CN¥-572.75 Million
2023 1.28% 2.72% 0.27x 1.78x CN¥-572.64 Million
2024 -6.26% -16.60% 0.21x 1.82x CN¥-979.25 Million
2025 -6.65% -20.42% 0.17x 1.87x CN¥-894.01 Million

Industry Comparison

This section compares Guangxi Wuzhou Zhongheng Group Co Ltd's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.

Industry Context

  • Industry: Drug Manufacturers - Specialty & Generic
  • Average net assets among peers: $1,554,577,785
  • Average return on equity (ROE) among peers: 7.31%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Guangxi Wuzhou Zhongheng Group Co Ltd (600252) CN¥6.63 Billion 17.74% 0.55x $1.02 Billion
Shenzhen Neptunus Bioengineering Co Ltd (000078) $1.45 Billion 1.52% 1.57x $485.12 Million
Anhui Fengyuan Pharmaceutical Co Ltd (000153) $576.00 Million 3.15% 0.28x $363.11 Million
Shan Dong Dong-E E-Jiao Co Ltd (000423) $1.12 Billion 13.25% 0.26x $4.79 Billion
Livzon Pharmaceutical Group Inc (000513) $623.47 Million 16.22% 0.40x $2.70 Billion
Wedge Industrial Co Ltd (000534) $654.70 Million 1.92% 0.87x $1.28 Billion
Yunnan Baiyao Group Co Ltd (000538) $184.00 Million 12.94% 0.09x $14.40 Billion
Hainan Haiyao Co Ltd (000566) $2.20 Billion -4.84% 2.35x $770.77 Million
Tus Pharmaceutical Group Co Ltd (000590) $728.20 Million 3.47% 0.58x $275.43 Million
Northeast Pharmaceutical Group Co Ltd (000597) $5.67 Billion 4.59% 1.27x $925.00 Million
Jilin Aodong Pharmaceutical Group Co Ltd (000623) $2.34 Billion 20.86% 0.40x $3.01 Billion

About Guangxi Wuzhou Zhongheng Group Co Ltd

SHG:600252 China Drug Manufacturers - Specialty & Generic
Market Cap
$1.02 Billion
CN¥6.97 Billion CNY
Market Cap Rank
#8501 Global
#1967 in China
Share Price
CN¥2.19
Change (1 day)
-2.23%
52-Week Range
CN¥1.76 - CN¥3.01
All Time High
CN¥7.62
About

Guangxi Wuzhou Zhongheng Group Co., Ltd, together with its subsidiaries, researches, develops, manufactures, and sells pharmaceuticals in China. The company offers traditional Chinese medicine, including Xueshuantong injection, Zhonghua Dieda Wan for traumatic injuries, Fuyanjing capsules, JieShiTong tablets, snake gall and fritillaria liquid, Kunyuean granules, and compound clam oral liquid for … Read more